BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20022216)

  • 1. Hepatitis C and interferon induced thyroiditis.
    Tomer Y
    J Autoimmun; 2010 May; 34(3):J322-6. PubMed ID: 20022216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon induced thyroiditis.
    Tomer Y; Menconi F
    Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23(6):703-12. PubMed ID: 19942147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental triggers of thyroiditis: hepatitis C and interferon-α.
    Menconi F; Hasham A; Tomer Y
    J Endocrinol Invest; 2011 Jan; 34(1):78-84. PubMed ID: 21297381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroid and hepatitis C].
    El Ouahabi H; Ajdi F
    Presse Med; 2012 Feb; 41(2):190-5. PubMed ID: 22251484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HCV antibodies in autoimmune thyroid disease.
    Testa A; Castaldi P; Fant V; Fiore GF; Grieco V; De Rosa A; Pazardjiklian MG; De Rosa G
    Eur Rev Med Pharmacol Sci; 2006; 10(4):183-6. PubMed ID: 16910348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways.
    Hasham A; Zhang W; Lotay V; Haggerty S; Stefan M; Concepcion E; Dieterich DT; Tomer Y
    J Autoimmun; 2013 Aug; 44():61-70. PubMed ID: 23683877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha treatment and thyroid dysfunction.
    Tomer Y; Blackard JT; Akeno N
    Endocrinol Metab Clin North Am; 2007 Dec; 36(4):1051-66; x-xi. PubMed ID: 17983936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
    Mandac JC; Chaudhry S; Sherman KE; Tomer Y
    Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
    Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
    J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
    Kakizaki S; Takagi H; Murakami M; Takayama H; Mori M
    J Hepatol; 1999 May; 30(5):794-800. PubMed ID: 10365804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A review on thyroid autoimmune disorders and HCV chronic infection].
    Di Domenicantonio A; Politti U; Marchi S; De Bortoli N; Giuggioli D; Antonelli A; Ferri C
    Clin Ter; 2014; 165(5):e376-81. PubMed ID: 25366958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.
    Ganne-Carrie N; Medini A; Coderc E; Seror O; Christidis C; Grimbert S; Trinchet JC; Beaugrand M
    J Autoimmun; 2000 Mar; 14(2):189-93. PubMed ID: 10677250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
    Peoc'h K; Dubel L; Chazouillères O; Ocwieja T; Duron F; Poupon R; Johanet C
    Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
    Krupińska J; Wawrzynowicz-Syczewska M; Urbanowicz W; Pobłocki J; Syrenicz A
    Endokrynol Pol; 2011; 62(6):517-22. PubMed ID: 22144218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does hepatitis c virus-related autoimmune thyroiditis exist? Reflections on a controlled study of 58 consecutive subjects].
    Blot E; Kerleau JM; Lévesque H; Héron F; Ménard JF; Buffet-Janvresse C; Bourreille J; Courtois H
    Rev Med Interne; 1999 Mar; 20(3):220-5. PubMed ID: 10216878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The etiology of autoimmune thyroid disease: a story of genes and environment.
    Tomer Y; Huber A
    J Autoimmun; 2009; 32(3-4):231-9. PubMed ID: 19307103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C virus infection and thyroid diseases].
    Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
    Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.
    Ghilardi G; Gonvers JJ; So A
    Br J Rheumatol; 1998 Dec; 37(12):1349-51. PubMed ID: 9973163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
    Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.